La Jolla, CA, United States of America

Hua Su

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hua Su. Retrieved from https://idiyas.com/inventor/hua-su-x08bvxjz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Hua Su

Introduction

Hua Su is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on developing effective therapies that target cancer cells.

Latest Patents

Hua Su holds a patent for a groundbreaking method titled "Combination therapy for cancer." This patent outlines methods and compositions for treating cancer by utilizing a combination of an inhibitor of macropinocytosis upregulation and an autophagy inhibitor. Additionally, it provides methods for inducing cell death in cancer cells and includes transgenic animal models related to these treatments. He has 1 patent to his name.

Career Highlights

Hua Su is affiliated with the University of California, where he conducts his research and develops his innovative therapies. His work has garnered attention for its potential to improve cancer treatment outcomes and enhance patient care.

Collaborations

Hua Su collaborates with Michael Karin, a fellow researcher, to further advance their understanding and treatment of cancer. Their partnership exemplifies the importance of teamwork in scientific research.

Conclusion

Hua Su's contributions to cancer treatment through his innovative patent demonstrate the potential for new therapies that can significantly impact patient outcomes. His work continues to inspire advancements in the field of oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…